TechDogs-"RLS NAMES RADIOPHARMACY AND HEALTHCARE LEADER TREY BANKSON AS NEW CHIEF OPERATING OFFICER"

Hiring News

RLS NAMES RADIOPHARMACY AND HEALTHCARE LEADER TREY BANKSON AS NEW CHIEF OPERATING OFFICER

By PR Newswire

PR Newswire
Overall Rating

Bankson's Appointment Marks the Latest in Recent Slate of Executive Hires to Position RLS for Long-Term, Sustainable Growth and Success

LAKE ZURICH, Ill., Oct. 31, 2022 /PRNewswire/ -- Today, RLS (USA) Inc., the third-largest nuclear medicine pharmacy network in the United States, named Trey Bankson as Chief Operating Officer, the latest in a recent slate of executive hires to advance RLS's vision for long-term, sustainable growth and success. Bankson, a 20-year veteran of the radiopharmacy and healthcare industry, will succeed Shane Cobb, who was appointed Chief Commercial Officer of RLS last week.

"Trey comes to RLS with over two decades of experience in conceptualizing and honing the day-to-day business operations of leading radiopharmacies across the country," said Stephen Belcher, CEO of RLS. "We are confident that his appointment as Chief Operating Officer will help advance our renewed commitment to sustainable growth and success, ensuring RLS continues to deliver critical diagnostics to doctors and hospitals nationwide, day in and day out."

As Chief Operating Officer, Bankson will be responsible for leading the day-to-day operations of the RLS network, which includes 31 radiopharmacies across 18 states. Bankson will play a key role in driving organizational alignment, operations strategy, and performance management for all RLS employees, from pharmacists and technicians in the labs, to couriers on the road. 

Bankson joined RLS after most recently serving as an executive healthcare consultant. Previously, he held senior operations roles at a wide range of pharmacies, including major radiopharmacies like Triad Isotopes—now part of Jubilant Radiopharma, the second-largest radiopharmaceutical network in the United States. He holds a BS in Pharmacy from Auburn University and an MS in Healthcare Administration from the University of Alabama at Birmingham.  

About RLS (USA) Inc.
 

RLS (USA) Inc., the third-largest nuclear medicine pharmacy network in the United States, owns and operates 31 radiopharmacies across 18 states, offering an extensive portfolio of molecular imaging products. We endeavor to supply the highest quality radiopharmaceuticals in the industry by dispensing 100 percent of injectable unit dose products in clean rooms built to ISO 1644-1 specifications. In support of our commitment to quality, we provide tailored solutions and exceptional service to our more than 1500 customers.

Media Contact

Amanda Penebaker 

amanda.penebaker@rls.bio  

https://rls.bio/

View original content:https://www.prnewswire.com/news-releases/rls-names-radiopharmacy-and-healthcare-leader-trey-bankson-as-new-chief-operating-officer-301663391.html

SOURCE RLS (USA) Inc.

Like what you read? Head to the TechDogs homepage to find the latest tech content infused with drama and entertainment. We've got ArticlesWhite PapersCase StudiesReportsVideos and Events - the complete lot to help you Know Your World of Technology.

First published on Mon, Oct 31, 2022

Enjoyed what you read? Great news – there’s a lot more to explore!

Dive into our content repository of the latest tech news, a diverse range of articles spanning introductory guides, product reviews, trends and more, along with engaging interviews, up-to-date AI blogs and hilarious tech memes!

Also explore our collection of branded insights via informative white papers, enlightening case studies, in-depth reports, educational videos and exciting events and webinars from leading global brands.

Head to the TechDogs homepage to Know Your World of technology today!

Disclaimer - Reference to any specific product, software or entity does not constitute an endorsement or recommendation by TechDogs nor should any data or content published be relied upon. The views expressed by TechDogs' members and guests are their own and their appearance on our site does not imply an endorsement of them or any entity they represent. Views and opinions expressed by TechDogs' Authors are those of the Authors and do not necessarily reflect the view of TechDogs or any of its officials. While we aim to provide valuable and helpful information, some content on TechDogs' site may not have been thoroughly reviewed for every detail or aspect. We encourage users to verify any information independently where necessary.

Join The Discussion

Join Our Newsletter

Get weekly news, engaging articles, and career tips-all free!

By subscribing to our newsletter, you're cool with our terms and conditions and agree to our Privacy Policy.

  • Dark
  • Light